Lanreotide Acetate
Active substance: lanreotide
INJECTION · LANREOTIDE ACETATE 90 mg/.3mL
United StatesActive
Marketing holder: Cipla USA Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- LANREOTIDE ACETATE · 90 mg/.3mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-ac12-74de-b8e5-2cdb068f3f87,01a1208c-b43a-76d7-bcad-3649e308d500,01a1208c-d38e-7067-ac7d-63b452f6cec9,01a1208c-fcc2-7c8d-91a7-aed8c74686af,01a1208c-fcc5-7a7a-845d-fb9e5e8a5566;count=13 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 69097-890
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 69097-890 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 69097-890 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 69097-890 · Verified 2026-10-09 · open in source